These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The frontal assessment battery in the differential diagnosis of dementia. Boban M, Malojcić B, Mimica N, Vuković S, Zrilić I. J Geriatr Psychiatry Neurol; 2012 Dec; 25(4):201-7. PubMed ID: 23172762 [Abstract] [Full Text] [Related]
4. Subscores of the FAB differentiate frontotemporal lobar degeneration from AD. Lipton AM, Ohman KA, Womack KB, Hynan LS, Ninman ET, Lacritz LH. Neurology; 2005 Sep 13; 65(5):726-31. PubMed ID: 16157906 [Abstract] [Full Text] [Related]
5. Validation of the German revised Addenbrooke's cognitive examination for detecting mild cognitive impairment, mild dementia in alzheimer's disease and frontotemporal lobar degeneration. Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J. Dement Geriatr Cogn Disord; 2010 Sep 13; 29(5):448-56. PubMed ID: 20502019 [Abstract] [Full Text] [Related]
6. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline]. Vanderzeypen F, Bier JC, Genevrois C, Mendlewicz J, Lotstra F. Encephale; 2003 Sep 13; 29(2):172-80. PubMed ID: 14567169 [Abstract] [Full Text] [Related]
7. Utility of behavioral versus cognitive measures in differentiating between subtypes of frontotemporal lobar degeneration and Alzheimer's disease. Heidler-Gary J, Gottesman R, Newhart M, Chang S, Ken L, Hillis AE. Dement Geriatr Cogn Disord; 2007 Sep 13; 23(3):184-93. PubMed ID: 17220629 [Abstract] [Full Text] [Related]
8. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction. Senanarong V, Cummings JL, Fairbanks L, Mega M, Masterman DM, O'Connor SM, Strickland TL. Dement Geriatr Cogn Disord; 2004 Sep 13; 17(1-2):14-20. PubMed ID: 14560060 [Abstract] [Full Text] [Related]
10. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice]. Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S. Encephale; 2003 Sep 13; 29(3 Pt 1):266-72. PubMed ID: 12876552 [Abstract] [Full Text] [Related]
11. The FTLD-modified Clinical Dementia Rating scale is a reliable tool for defining disease severity in frontotemporal lobar degeneration: evidence from a brain SPECT study. Borroni B, Agosti C, Premi E, Cerini C, Cosseddu M, Paghera B, Bellelli G, Padovani A. Eur J Neurol; 2010 May 13; 17(5):703-7. PubMed ID: 20050899 [Abstract] [Full Text] [Related]
14. Amyloid precursor protein expression is enhanced in human platelets from subjects with Alzheimer's disease and frontotemporal lobar degeneration: a real-time PCR study. Vignini A, Morganti S, Salvolini E, Sartini D, Luzzi S, Fiorini R, Provinciali L, Di Primio R, Mazzanti L, Emanuelli M. Exp Gerontol; 2013 Dec 13; 48(12):1505-8. PubMed ID: 24400342 [Abstract] [Full Text] [Related]
15. The frontal assessment battery does not differentiate frontotemporal dementia from Alzheimer's disease. Castiglioni S, Pelati O, Zuffi M, Somalvico F, Marino L, Tentorio T, Franceschi M. Dement Geriatr Cogn Disord; 2006 Dec 13; 22(2):125-31. PubMed ID: 16733354 [Abstract] [Full Text] [Related]
16. Neuropsychological Assessment in the Distinction Between Biomarker Defined Frontal-Variant of Alzheimer's Disease and Behavioral-Variant of Frontotemporal Dementia. Lima M, Tábuas-Pereira M, Durães J, Vieira D, Faustino P, Baldeiras I, Santana I. J Alzheimers Dis; 2023 Dec 13; 91(4):1303-1312. PubMed ID: 36617783 [Abstract] [Full Text] [Related]